相关实验视频
Updated: May 12, 2026

10:12
The MPLEx Protocol for Multi-omic Analyses of Soil Samples
Published on: May 30, 2018
11.0K
脂质新陈代谢,甲基化异常和骨质疏松症:基于孟德尔随机化的多组学研究
ZhaoLiang Zhang1, YuChen Duan1, JianZhong Huo2
1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Calcified tissue international
|December 10, 2023
概括
这项研究揭示了脱脂症和骨质疏松症之间的因果关系,可能由DNA甲基化介导. 异常甲基化可能弥合血脂代谢和骨矿物质密度,为疾病机制提供新的见解.
科学领域:
- 遗传学和表观遗传学
- 代谢障碍 代谢障碍 代谢障碍
- 骨健康 骨健康 骨健康
背景情况:
- 观察性研究表明,脱脂症和骨质疏松症有联系,但遗传原因和机制尚不清楚.
- 以前的研究受到混因素和偏见的限制,阻碍了因果推理.
- 像DNA甲基化这样的表观遗传修饰与疾病有关,但它们在链接脂质代谢和骨质疏松症中的作用尚未被探索.
研究的目的:
- 通过使用遗传数据,研究脂质谱和骨矿物质密度 (BMD) 之间的因果关系.
- 探索DNA甲基化在调解脱脂症对骨质疏松症影响中的潜在作用.
主要方法:
- 利用两个样本的门德尔随机化与全基因组关联研究数据的脂质资料和BMD.
- 采用基于总结数据的门德尔随机化 (SMR) 方法来评估甲基化位点对脂质形状和骨质量的遗传影响.
主要成果:
- 在高胆固醇血症,LDL-C,VLDL-C,HDL-C,Apo B和Apo A1之间确认了负面因果关联,在各个部位减少了BMD.
- 确定了三个甲基化位点 (cg15707428,cg16000331,cg14364472),与脂质样本和对骨的遗传影响有关.
- 灵敏度分析表明没有显著的水平质.
结论:
- 这些发现表明,脂症和骨质疏松症之间存在潜在的因果关系和共同致病.
- 异常的DNA甲基化修改可能在脱脂症对骨质疏松症的遗传影响中发挥桥梁作用.
相关概念视频
Regulation of Metabolism
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

